

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * detection of visible light (GO:0009584) | 9.87825034 |
| 2 | * detection of light stimulus (GO:0009583) | 9.83227790 |
| 3 | GMP metabolic process (GO:0046037) | 9.42672316 |
| 4 | positive regulation of guanylate cyclase activity (GO:0031284) | 8.67882164 |
| 5 | * visual perception (GO:0007601) | 8.67526686 |
| 6 | * sensory perception of light stimulus (GO:0050953) | 8.57505841 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 7.83357712 |
| 8 | cellular response to light stimulus (GO:0071482) | 7.47599466 |
| 9 | * detection of external stimulus (GO:0009581) | 6.86505482 |
| 10 | photoreceptor cell differentiation (GO:0046530) | 6.81387121 |
| 11 | eye photoreceptor cell differentiation (GO:0001754) | 6.81387121 |
| 12 | * detection of abiotic stimulus (GO:0009582) | 6.73148188 |
| 13 | retina development in camera-type eye (GO:0060041) | 6.47739030 |
| 14 | polyketide metabolic process (GO:0030638) | 6.03444352 |
| 15 | doxorubicin metabolic process (GO:0044598) | 6.03444352 |
| 16 | daunorubicin metabolic process (GO:0044597) | 6.03444352 |
| 17 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.79651877 |
| 18 | cellular response to electrical stimulus (GO:0071257) | 5.75234091 |
| 19 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.72080070 |
| 20 | regulation of cGMP metabolic process (GO:0030823) | 5.65578973 |
| 21 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.12171036 |
| 22 | cellular response to radiation (GO:0071478) | 4.85995529 |
| 23 | regulation of cGMP biosynthetic process (GO:0030826) | 4.80278933 |
| 24 | adaptation of signaling pathway (GO:0023058) | 4.71681907 |
| 25 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.69877267 |
| 26 | nonmotile primary cilium assembly (GO:0035058) | 4.65699110 |
| 27 | positive regulation of cGMP metabolic process (GO:0030825) | 4.51632762 |
| 28 | retinal metabolic process (GO:0042574) | 4.51459902 |
| 29 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.42740511 |
| 30 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.42437324 |
| 31 | estrogen biosynthetic process (GO:0006703) | 4.35454744 |
| 32 | surfactant homeostasis (GO:0043129) | 4.31368948 |
| 33 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.26223808 |
| 34 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.22989384 |
| 35 | * sensory perception (GO:0007600) | 4.07253536 |
| 36 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.06196530 |
| 37 | endothelium development (GO:0003158) | 4.05042958 |
| 38 | retina layer formation (GO:0010842) | 4.03151783 |
| 39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.01795141 |
| 40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.87674646 |
| 41 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.84401065 |
| 42 | * response to light stimulus (GO:0009416) | 3.78514981 |
| 43 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.78405124 |
| 44 | chemical homeostasis within a tissue (GO:0048875) | 3.63627791 |
| 45 | neuron development (GO:0048666) | 3.57859135 |
| 46 | protein prenylation (GO:0018342) | 3.43923295 |
| 47 | prenylation (GO:0097354) | 3.43923295 |
| 48 | protein localization to synapse (GO:0035418) | 3.38435781 |
| 49 | semaphorin-plexin signaling pathway (GO:0071526) | 3.33308654 |
| 50 | behavioral response to ethanol (GO:0048149) | 3.31021084 |
| 51 | membrane hyperpolarization (GO:0060081) | 3.30762432 |
| 52 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.26184951 |
| 53 | paraxial mesoderm development (GO:0048339) | 3.24736489 |
| 54 | heme transport (GO:0015886) | 3.23278245 |
| 55 | retina homeostasis (GO:0001895) | 3.23213914 |
| 56 | response to pheromone (GO:0019236) | 3.20800356 |
| 57 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.20734897 |
| 58 | primary alcohol catabolic process (GO:0034310) | 3.16311744 |
| 59 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.15415215 |
| 60 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.15080983 |
| 61 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.14716351 |
| 62 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.11856748 |
| 63 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.11246025 |
| 64 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.08860303 |
| 65 | bone remodeling (GO:0046849) | 3.08024672 |
| 66 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07447319 |
| 67 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.05596119 |
| 68 | fat-soluble vitamin metabolic process (GO:0006775) | 3.01339718 |
| 69 | hippo signaling (GO:0035329) | 3.00412804 |
| 70 | piRNA metabolic process (GO:0034587) | 2.98826896 |
| 71 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.98690507 |
| 72 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.94150137 |
| 73 | short-term memory (GO:0007614) | 2.91409114 |
| 74 | chemosensory behavior (GO:0007635) | 2.90952251 |
| 75 | response to histamine (GO:0034776) | 2.89536135 |
| 76 | intestinal cholesterol absorption (GO:0030299) | 2.89399569 |
| 77 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.87588736 |
| 78 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.87588736 |
| 79 | synaptic vesicle maturation (GO:0016188) | 2.85654616 |
| 80 | quaternary ammonium group transport (GO:0015697) | 2.85387971 |
| 81 | axoneme assembly (GO:0035082) | 2.84480388 |
| 82 | glycoside metabolic process (GO:0016137) | 2.83176763 |
| 83 | retinol metabolic process (GO:0042572) | 2.82124315 |
| 84 | gap junction assembly (GO:0016264) | 2.81305008 |
| 85 | zinc ion transmembrane transport (GO:0071577) | 2.80517308 |
| 86 | negative regulation of complement activation (GO:0045916) | 2.79048766 |
| 87 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.78046216 |
| 88 | * retinoid metabolic process (GO:0001523) | 2.76892225 |
| 89 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.74380248 |
| 90 | regulation of penile erection (GO:0060405) | 2.72133001 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 2.71055148 |
| 92 | desmosome organization (GO:0002934) | 2.70654916 |
| 93 | embryonic foregut morphogenesis (GO:0048617) | 2.68000361 |
| 94 | neuron remodeling (GO:0016322) | 2.67498619 |
| 95 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.66964835 |
| 96 | post-embryonic morphogenesis (GO:0009886) | 2.65038968 |
| 97 | negative regulation of protein activation cascade (GO:2000258) | 2.63165657 |
| 98 | polyol transport (GO:0015791) | 2.63109656 |
| 99 | regulation of hippo signaling (GO:0035330) | 2.62825521 |
| 100 | cell differentiation involved in metanephros development (GO:0072202) | 2.62379796 |
| 101 | primary alcohol metabolic process (GO:0034308) | 2.61852097 |
| 102 | notochord development (GO:0030903) | 2.60903733 |
| 103 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.59647068 |
| 104 | * response to radiation (GO:0009314) | 2.58959878 |
| 105 | lymphangiogenesis (GO:0001946) | 2.58750265 |
| 106 | keratan sulfate catabolic process (GO:0042340) | 2.57079818 |
| 107 | * diterpenoid metabolic process (GO:0016101) | 2.56461255 |
| 108 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.56206289 |
| 109 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.55708597 |
| 110 | biotin metabolic process (GO:0006768) | 2.54232140 |
| 111 | cell-cell junction maintenance (GO:0045217) | 2.53779966 |
| 112 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.52756827 |
| 113 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.52182084 |
| 114 | sodium ion export (GO:0071436) | 2.51656969 |
| 115 | embryonic heart tube development (GO:0035050) | 2.50105854 |
| 116 | vitamin A metabolic process (GO:0006776) | 2.50052123 |
| 117 | positive regulation of hormone metabolic process (GO:0032352) | 2.49655806 |
| 118 | cellular response to abiotic stimulus (GO:0071214) | 2.49213304 |
| 119 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.48722880 |
| 120 | arachidonic acid secretion (GO:0050482) | 2.47426531 |
| 121 | icosanoid secretion (GO:0032309) | 2.47426531 |
| 122 | lung-associated mesenchyme development (GO:0060484) | 2.47373512 |
| 123 | dopamine receptor signaling pathway (GO:0007212) | 2.46878342 |
| 124 | * isoprenoid metabolic process (GO:0006720) | 2.46513550 |
| 125 | endothelial cell differentiation (GO:0045446) | 2.46285247 |
| 126 | negative regulation of cation channel activity (GO:2001258) | 2.46138544 |
| 127 | righting reflex (GO:0060013) | 2.45893121 |
| 128 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.43983494 |
| 129 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.43983494 |
| 130 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.42572009 |
| 131 | smooth muscle tissue development (GO:0048745) | 2.39616207 |
| 132 | potassium ion homeostasis (GO:0055075) | 2.39353737 |
| 133 | apical protein localization (GO:0045176) | 2.37995089 |
| 134 | genitalia morphogenesis (GO:0035112) | 2.36527630 |
| 135 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.36367116 |
| 136 | mitochondrion transport along microtubule (GO:0047497) | 2.36295499 |
| 137 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.36295499 |
| 138 | hair cell differentiation (GO:0035315) | 2.35806360 |
| 139 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.35317332 |
| 140 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.35137821 |
| 141 | synaptonemal complex assembly (GO:0007130) | 2.35086206 |
| 142 | cell junction maintenance (GO:0034331) | 2.33166586 |
| 143 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.32388375 |
| 144 | * terpenoid metabolic process (GO:0006721) | 2.32151241 |
| 145 | lymph vessel development (GO:0001945) | 2.30855449 |
| 146 | peripheral nervous system development (GO:0007422) | 2.30273588 |
| 147 | lipoprotein transport (GO:0042953) | 2.29499587 |
| 148 | non-canonical Wnt signaling pathway (GO:0035567) | 2.28736775 |
| 149 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.28296855 |
| 150 | tight junction assembly (GO:0070830) | 2.28136091 |
| 151 | modified amino acid transport (GO:0072337) | 2.27509750 |
| 152 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.25407195 |
| 153 | asymmetric protein localization (GO:0008105) | 2.25267776 |
| 154 | cell-cell junction assembly (GO:0007043) | 2.24934578 |
| 155 | trivalent inorganic anion homeostasis (GO:0072506) | 2.24597895 |
| 156 | phosphate ion homeostasis (GO:0055062) | 2.24597895 |
| 157 | response to nitrosative stress (GO:0051409) | 2.24005972 |
| 158 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.23200373 |
| 159 | drug transmembrane transport (GO:0006855) | 2.22766384 |
| 160 | facial nerve structural organization (GO:0021612) | 2.22353160 |
| 161 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 17.8540333 |
| 162 | rhodopsin mediated signaling pathway (GO:0016056) | 17.5505067 |
| 163 | retinal cone cell development (GO:0046549) | 14.8322223 |
| 164 | photoreceptor cell development (GO:0042461) | 11.9394772 |
| 165 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.6772785 |
| 166 | detection of light stimulus involved in visual perception (GO:0050908) | 11.6772785 |
| 167 | eye photoreceptor cell development (GO:0042462) | 11.3360495 |
| 168 | * photoreceptor cell maintenance (GO:0045494) | 11.1102809 |
| 169 | protein-chromophore linkage (GO:0018298) | 10.4556013 |
| 170 | * phototransduction (GO:0007602) | 10.3430799 |
| 171 | * phototransduction, visible light (GO:0007603) | 10.2995061 |
| 172 | retinal rod cell development (GO:0046548) | 10.2772306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.71605710 |
| 2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.66851344 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.52762073 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17554822 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54398027 |
| 6 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.44055803 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36693634 |
| 8 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 2.21949613 |
| 9 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.19760094 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16841765 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12762964 |
| 12 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.08192673 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03119766 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.00813037 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99610737 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95920606 |
| 17 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94719444 |
| 18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86106529 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.85761726 |
| 20 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.85644995 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85622790 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83812793 |
| 23 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.82675336 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.80605201 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79698905 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78368469 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.77342836 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75239597 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.73940654 |
| 30 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.72525784 |
| 31 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.72350344 |
| 32 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.71491341 |
| 33 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.71486039 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68463999 |
| 35 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.67125220 |
| 36 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.67125220 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66975125 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63639419 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63502313 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61436242 |
| 41 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.61093528 |
| 42 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.59875791 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58097220 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56972289 |
| 45 | * AR_19668381_ChIP-Seq_PC3_Human | 1.56917100 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56637047 |
| 47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56494929 |
| 48 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.55858756 |
| 49 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.53470225 |
| 50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52114394 |
| 51 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50067579 |
| 52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.49986586 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48196495 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.47745191 |
| 55 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.47745191 |
| 56 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47347316 |
| 57 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.46260668 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.45387590 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45295917 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44760503 |
| 61 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44619627 |
| 62 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41341257 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41081698 |
| 64 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36261287 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35752424 |
| 66 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.32400574 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32021354 |
| 68 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28905836 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28821627 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28526520 |
| 71 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27926647 |
| 72 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.27726175 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26557223 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26099004 |
| 75 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.25094052 |
| 76 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23601785 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22536988 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22240065 |
| 79 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22049938 |
| 80 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21289409 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19637194 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17784638 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17571537 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17403887 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17137490 |
| 86 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16841260 |
| 87 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.16031004 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15813807 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15800480 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.15663858 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15639464 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13185343 |
| 93 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12646261 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12316091 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12223289 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11994437 |
| 97 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.11946531 |
| 98 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.11690053 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09780799 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09457392 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09076541 |
| 102 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08910794 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08906242 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08906242 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08193882 |
| 106 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06292935 |
| 107 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05989161 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05804336 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04014440 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04012128 |
| 111 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03846536 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03766758 |
| 113 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03685325 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03353631 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02807642 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02706186 |
| 117 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02497034 |
| 118 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01956557 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01941977 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01749614 |
| 121 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01408394 |
| 122 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00920223 |
| 123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00436039 |
| 124 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.00153291 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99272011 |
| 126 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.98694373 |
| 127 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98687247 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98542630 |
| 129 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98290605 |
| 130 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97887793 |
| 131 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97887793 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.97630042 |
| 133 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97500561 |
| 134 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.97403196 |
| 135 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97211597 |
| 136 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.96860374 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95643551 |
| 138 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94684635 |
| 139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94448293 |
| 140 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94394241 |
| 141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94256092 |
| 142 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94042813 |
| 143 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94038649 |
| 144 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93969905 |
| 145 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93235995 |
| 146 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93212285 |
| 147 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93092299 |
| 148 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.92909943 |
| 149 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.92864966 |
| 150 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.92757485 |
| 151 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92639124 |
| 152 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.92368837 |
| 153 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.91175576 |
| 154 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90483746 |
| 155 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90446147 |
| 156 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89903762 |
| 157 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89694106 |
| 158 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89694106 |
| 159 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89234556 |
| 160 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88042137 |
| 161 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87748464 |
| 162 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87721153 |
| 163 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87303604 |
| 164 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87124094 |
| 165 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86964508 |
| 166 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.86488791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.48761346 |
| 2 | * MP0005253_abnormal_eye_physiology | 6.56942212 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.45143207 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.90425124 |
| 5 | * MP0005195_abnormal_posterior_eye | 3.79496902 |
| 6 | MP0002090_abnormal_vision | 3.31979134 |
| 7 | MP0006054_spinal_hemorrhage | 3.24934122 |
| 8 | * MP0001324_abnormal_eye_pigmentation | 3.21641152 |
| 9 | * MP0005391_vision/eye_phenotype | 3.20247708 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 2.95271074 |
| 11 | MP0003878_abnormal_ear_physiology | 2.95271074 |
| 12 | MP0002638_abnormal_pupillary_reflex | 2.60534514 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.51411330 |
| 14 | * MP0002229_neurodegeneration | 2.49425053 |
| 15 | MP0003011_delayed_dark_adaptation | 11.7009298 |
| 16 | MP0004272_abnormal_basement_membrane | 1.94676966 |
| 17 | MP0000383_abnormal_hair_follicle | 1.90840707 |
| 18 | * MP0002752_abnormal_somatic_nervous | 1.86772953 |
| 19 | MP0001764_abnormal_homeostasis | 1.85940380 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.72157477 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.71738288 |
| 22 | MP0003195_calcinosis | 1.66872212 |
| 23 | MP0000647_abnormal_sebaceous_gland | 1.66437223 |
| 24 | MP0010678_abnormal_skin_adnexa | 1.60427858 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.60157188 |
| 26 | MP0000566_synostosis | 1.58344845 |
| 27 | MP0002098_abnormal_vibrissa_morphology | 1.55086930 |
| 28 | MP0004233_abnormal_muscle_weight | 1.36681969 |
| 29 | * MP0002882_abnormal_neuron_morphology | 1.33747280 |
| 30 | MP0001502_abnormal_circadian_rhythm | 1.33190478 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.24951195 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.20370810 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.20315794 |
| 34 | MP0005409_darkened_coat_color | 1.16198735 |
| 35 | MP0005360_urolithiasis | 1.12695767 |
| 36 | MP0002168_other_aberrant_phenotype | 1.11456259 |
| 37 | MP0004885_abnormal_endolymph | 1.06563132 |
| 38 | MP0005275_abnormal_skin_tensile | 1.05873103 |
| 39 | MP0001984_abnormal_olfaction | 1.05389050 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.03315505 |
| 41 | MP0005395_other_phenotype | 0.97438622 |
| 42 | MP0005394_taste/olfaction_phenotype | 0.93600233 |
| 43 | MP0005499_abnormal_olfactory_system | 0.93600233 |
| 44 | MP0001486_abnormal_startle_reflex | 0.91499643 |
| 45 | MP0002092_abnormal_eye_morphology | 0.90482350 |
| 46 | MP0003941_abnormal_skin_development | 0.89053985 |
| 47 | MP0004270_analgesia | 0.86257534 |
| 48 | MP0000537_abnormal_urethra_morphology | 0.86081336 |
| 49 | MP0003385_abnormal_body_wall | 0.83559213 |
| 50 | MP0002332_abnormal_exercise_endurance | 0.83498466 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 0.82795861 |
| 52 | MP0000377_abnormal_hair_follicle | 0.81743941 |
| 53 | MP0008789_abnormal_olfactory_epithelium | 0.80653340 |
| 54 | MP0003879_abnormal_hair_cell | 0.80647080 |
| 55 | MP0000579_abnormal_nail_morphology | 0.79183321 |
| 56 | MP0003718_maternal_effect | 0.78238091 |
| 57 | MP0002822_catalepsy | 0.76945002 |
| 58 | MP0001958_emphysema | 0.76471964 |
| 59 | MP0000427_abnormal_hair_cycle | 0.75594697 |
| 60 | MP0003329_amyloid_beta_deposits | 0.72235162 |
| 61 | MP0003634_abnormal_glial_cell | 0.71769657 |
| 62 | * MP0004019_abnormal_vitamin_homeostasis | 0.70800982 |
| 63 | MP0000767_abnormal_smooth_muscle | 0.67373188 |
| 64 | MP0003252_abnormal_bile_duct | 0.66653574 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.65800980 |
| 66 | MP0005248_abnormal_Harderian_gland | 0.65689541 |
| 67 | MP0002272_abnormal_nervous_system | 0.64154902 |
| 68 | MP0001286_abnormal_eye_development | 0.63753944 |
| 69 | MP0005023_abnormal_wound_healing | 0.63289542 |
| 70 | MP0003935_abnormal_craniofacial_develop | 0.62096301 |
| 71 | MP0008775_abnormal_heart_ventricle | 0.61233951 |
| 72 | MP0010030_abnormal_orbit_morphology | 0.60325591 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.60165862 |
| 74 | MP0006138_congestive_heart_failure | 0.59761466 |
| 75 | MP0005187_abnormal_penis_morphology | 0.58859163 |
| 76 | MP0005670_abnormal_white_adipose | 0.57791320 |
| 77 | MP0003880_abnormal_central_pattern | 0.57707310 |
| 78 | MP0000516_abnormal_urinary_system | 0.55436771 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 0.55436771 |
| 80 | MP0003984_embryonic_growth_retardation | 0.55353219 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.54570033 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.54312435 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.54046251 |
| 84 | * MP0002925_abnormal_cardiovascular_devel | 0.54016848 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 0.53938621 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.53739954 |
| 87 | MP0005503_abnormal_tendon_morphology | 0.53736471 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.53003968 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 0.52619784 |
| 90 | MP0002233_abnormal_nose_morphology | 0.52270862 |
| 91 | MP0003119_abnormal_digestive_system | 0.51131171 |
| 92 | MP0002064_seizures | 0.51091804 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.49989745 |
| 94 | * MP0005197_abnormal_uvea_morphology | 0.49836081 |
| 95 | MP0005647_abnormal_sex_gland | 0.49442726 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.49420635 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 0.49356852 |
| 98 | MP0003942_abnormal_urinary_system | 0.49027774 |
| 99 | MP0001672_abnormal_embryogenesis/_devel | 0.48202730 |
| 100 | MP0005380_embryogenesis_phenotype | 0.48202730 |
| 101 | MP0004859_abnormal_synaptic_plasticity | 0.47613328 |
| 102 | MP0009046_muscle_twitch | 0.46923771 |
| 103 | MP0000428_abnormal_craniofacial_morphol | 0.46911918 |
| 104 | MP0003937_abnormal_limbs/digits/tail_de | 0.46482861 |
| 105 | MP0002084_abnormal_developmental_patter | 0.45566955 |
| 106 | MP0008004_abnormal_stomach_pH | 0.44964005 |
| 107 | * MP0001614_abnormal_blood_vessel | 0.44903248 |
| 108 | MP0009697_abnormal_copulation | 0.44890787 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.44577481 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.43593489 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 0.39824843 |
| 112 | MP0003045_fibrosis | 0.39631515 |
| 113 | MP0002067_abnormal_sensory_capabilities | 0.39204104 |
| 114 | MP0002063_abnormal_learning/memory/cond | 0.38599885 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.37835167 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.36476516 |
| 117 | MP0002697_abnormal_eye_size | 0.36424953 |
| 118 | MP0002102_abnormal_ear_morphology | 0.36374187 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.35751463 |
| 120 | MP0004924_abnormal_behavior | 0.34814590 |
| 121 | MP0005386_behavior/neurological_phenoty | 0.34814590 |
| 122 | MP0002572_abnormal_emotion/affect_behav | 0.32211946 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.31923082 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.31572527 |
| 125 | MP0004085_abnormal_heartbeat | 0.31213922 |
| 126 | MP0009745_abnormal_behavioral_response | 0.29823161 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.29678816 |
| 128 | MP0000026_abnormal_inner_ear | 0.27508781 |
| 129 | MP0003943_abnormal_hepatobiliary_system | 0.27376526 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.27184024 |
| 131 | MP0005193_abnormal_anterior_eye | 0.25434588 |
| 132 | MP0008569_lethality_at_weaning | 0.24685610 |
| 133 | MP0002152_abnormal_brain_morphology | 0.24018948 |
| 134 | MP0004043_abnormal_pH_regulation | 0.23821166 |
| 135 | MP0005646_abnormal_pituitary_gland | 0.23539222 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.23353304 |
| 137 | MP0002928_abnormal_bile_duct | 0.23266163 |
| 138 | MP0002234_abnormal_pharynx_morphology | 0.23238127 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.23136426 |
| 140 | MP0004742_abnormal_vestibular_system | 0.22941972 |
| 141 | MP0001346_abnormal_lacrimal_gland | 0.21422611 |
| 142 | MP0001915_intracranial_hemorrhage | 0.21272806 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.21250442 |
| 144 | MP0002184_abnormal_innervation | 0.21096847 |
| 145 | MP0002066_abnormal_motor_capabilities/c | 0.18862475 |
| 146 | MP0005330_cardiomyopathy | 0.17541634 |
| 147 | MP0000778_abnormal_nervous_system | 0.17054960 |
| 148 | MP0004142_abnormal_muscle_tone | 0.16996650 |
| 149 | MP0005076_abnormal_cell_differentiation | 0.16819688 |
| 150 | MP0003633_abnormal_nervous_system | 0.16057277 |
| 151 | MP0003137_abnormal_impulse_conducting | 0.15692690 |
| 152 | MP0008961_abnormal_basal_metabolism | 0.15664676 |
| 153 | MP0002909_abnormal_adrenal_gland | 0.15044559 |
| 154 | MP0000749_muscle_degeneration | 0.14980760 |
| 155 | MP0001661_extended_life_span | 0.14433489 |
| 156 | MP0004811_abnormal_neuron_physiology | 0.14424176 |
| 157 | MP0003632_abnormal_nervous_system | 0.13985784 |
| 158 | MP0005257_abnormal_intraocular_pressure | 0.12278540 |
| 159 | MP0003646_muscle_fatigue | 0.12112776 |
| 160 | MP0000751_myopathy | 0.11493188 |
| 161 | MP0001293_anophthalmia | 0.11094113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 8.88107246 |
| 2 | Dyschromatopsia (HP:0007641) | 8.87507061 |
| 3 | Chorioretinal atrophy (HP:0000533) | 8.66150415 |
| 4 | Pendular nystagmus (HP:0012043) | 8.10553215 |
| 5 | Abolished electroretinogram (ERG) (HP:0000550) | 7.13298793 |
| 6 | * Central scotoma (HP:0000603) | 6.96720866 |
| 7 | * Scotoma (HP:0000575) | 6.87291497 |
| 8 | * Attenuation of retinal blood vessels (HP:0007843) | 6.84934535 |
| 9 | Decreased central vision (HP:0007663) | 6.82844181 |
| 10 | * Abnormality of macular pigmentation (HP:0008002) | 6.68321707 |
| 11 | * Photophobia (HP:0000613) | 5.75801836 |
| 12 | * Type II diabetes mellitus (HP:0005978) | 5.62643161 |
| 13 | Posterior subcapsular cataract (HP:0007787) | 5.42204884 |
| 14 | Severe visual impairment (HP:0001141) | 5.32506581 |
| 15 | Keratoconus (HP:0000563) | 5.20712374 |
| 16 | Increased corneal curvature (HP:0100692) | 5.20712374 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 4.99961761 |
| 18 | Constricted visual fields (HP:0001133) | 4.92264276 |
| 19 | Choroideremia (HP:0001139) | 4.89917210 |
| 20 | * Macular degeneration (HP:0000608) | 4.44657899 |
| 21 | * Retinitis pigmentosa (HP:0000510) | 4.16772802 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.09075242 |
| 23 | Progressive visual loss (HP:0000529) | 3.48011762 |
| 24 | Subcapsular cataract (HP:0000523) | 3.41727462 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 3.22743508 |
| 26 | Tubulointerstitial nephritis (HP:0001970) | 3.12359478 |
| 27 | Hypopigmentation of the fundus (HP:0007894) | 3.10803290 |
| 28 | Retinal atrophy (HP:0001105) | 3.10662775 |
| 29 | * Cone-rod dystrophy (HP:0000548) | 3.07420692 |
| 30 | Hypoplasia of the iris (HP:0007676) | 2.85163364 |
| 31 | Proximal tubulopathy (HP:0000114) | 2.75069396 |
| 32 | Ulnar claw (HP:0001178) | 2.66297120 |
| 33 | Action tremor (HP:0002345) | 2.63662221 |
| 34 | Optic disc pallor (HP:0000543) | 2.56658466 |
| 35 | * Wide nasal bridge (HP:0000431) | 2.51468292 |
| 36 | Vascular calcification (HP:0004934) | 2.45000165 |
| 37 | Termporal pattern (HP:0011008) | 2.35807750 |
| 38 | Insidious onset (HP:0003587) | 2.35807750 |
| 39 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.28278461 |
| 40 | Gait imbalance (HP:0002141) | 2.27148973 |
| 41 | Congenital primary aphakia (HP:0007707) | 2.26518900 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.18896519 |
| 43 | Glomerulonephritis (HP:0000099) | 2.13272937 |
| 44 | Myocardial infarction (HP:0001658) | 2.05856189 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01686063 |
| 46 | Tubulointerstitial abnormality (HP:0001969) | 2.00519570 |
| 47 | Congenital stationary night blindness (HP:0007642) | 14.9774266 |
| 48 | * Bony spicule pigmentary retinopathy (HP:0007737) | 11.3167525 |
| 49 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.7867502 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.3483187 |
| 51 | Bronchomalacia (HP:0002780) | 1.98862034 |
| 52 | Upper limb muscle weakness (HP:0003484) | 1.95336379 |
| 53 | Increased circulating renin level (HP:0000848) | 1.93253243 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92537116 |
| 55 | Subacute progressive viral hepatitis (HP:0006572) | 1.92337496 |
| 56 | Nephritis (HP:0000123) | 1.91479623 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 1.90331175 |
| 58 | Rhinitis (HP:0012384) | 1.90213556 |
| 59 | Polar cataract (HP:0010696) | 1.87336937 |
| 60 | Renal tubular acidosis (HP:0001947) | 1.86890486 |
| 61 | Hyperactive renin-angiotensin system (HP:0000841) | 1.86300994 |
| 62 | Asymmetry of the thorax (HP:0001555) | 1.86255442 |
| 63 | Hydroxyprolinuria (HP:0003080) | 1.84170111 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 1.84170111 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 1.84023546 |
| 66 | Tubular atrophy (HP:0000092) | 1.82451767 |
| 67 | Cutaneous finger syndactyly (HP:0010554) | 1.81999600 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 1.81801915 |
| 69 | Short nail (HP:0001799) | 1.81004622 |
| 70 | Progressive sensorineural hearing impairment (HP:0000408) | 1.78494304 |
| 71 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.77298863 |
| 72 | Hypoplastic labia majora (HP:0000059) | 1.77210618 |
| 73 | Poor coordination (HP:0002370) | 1.74081811 |
| 74 | Esophageal varix (HP:0002040) | 1.73817619 |
| 75 | Hemorrhage of the eye (HP:0011885) | 1.71582994 |
| 76 | Horizontal nystagmus (HP:0000666) | 1.66614138 |
| 77 | True hermaphroditism (HP:0010459) | 1.65830450 |
| 78 | Cervical subluxation (HP:0003308) | 1.65210610 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 1.65069445 |
| 80 | Abnormal pupillary function (HP:0007686) | 1.64720146 |
| 81 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.64365328 |
| 82 | Bell-shaped thorax (HP:0001591) | 1.63927125 |
| 83 | Absent eyebrow (HP:0002223) | 1.63869948 |
| 84 | Abnormality of the dental root (HP:0006486) | 1.61992233 |
| 85 | Taurodontia (HP:0000679) | 1.61992233 |
| 86 | Abnormality of permanent molar morphology (HP:0011071) | 1.61992233 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 1.60323084 |
| 88 | Abnormality of the renal medulla (HP:0100957) | 1.60254239 |
| 89 | Abnormality of the labia majora (HP:0012881) | 1.60203858 |
| 90 | Nonimmune hydrops fetalis (HP:0001790) | 1.59741301 |
| 91 | Bicornuate uterus (HP:0000813) | 1.59507762 |
| 92 | * Optic atrophy (HP:0000648) | 1.57790419 |
| 93 | Pancreatic fibrosis (HP:0100732) | 1.57489381 |
| 94 | Abnormality of the fovea (HP:0000493) | 1.57456012 |
| 95 | Protrusio acetabuli (HP:0003179) | 1.56937647 |
| 96 | Vaginal atresia (HP:0000148) | 1.56895672 |
| 97 | Ulnar bowing (HP:0003031) | 1.56688974 |
| 98 | Renal salt wasting (HP:0000127) | 1.56635207 |
| 99 | Abnormality of the dental pulp (HP:0006479) | 1.56141752 |
| 100 | Complement deficiency (HP:0004431) | 1.55936974 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.55265529 |
| 102 | Abnormality of molar morphology (HP:0011070) | 1.52960707 |
| 103 | Abnormality of molar (HP:0011077) | 1.52960707 |
| 104 | Decreased lacrimation (HP:0000633) | 1.52602503 |
| 105 | Abnormal ciliary motility (HP:0012262) | 1.52590489 |
| 106 | Tubulointerstitial fibrosis (HP:0005576) | 1.51774573 |
| 107 | Micronodular cirrhosis (HP:0001413) | 1.51513918 |
| 108 | Increased CSF protein (HP:0002922) | 1.51374663 |
| 109 | Severe Myopia (HP:0011003) | 1.50844598 |
| 110 | Abnormal auditory evoked potentials (HP:0006958) | 1.50744251 |
| 111 | Hyperkalemia (HP:0002153) | 1.50462046 |
| 112 | Genital tract atresia (HP:0001827) | 1.50320161 |
| 113 | Sex reversal (HP:0012245) | 1.49638516 |
| 114 | Abnormal sex determination (HP:0012244) | 1.49638516 |
| 115 | Epidermoid cyst (HP:0200040) | 1.48149037 |
| 116 | Advanced eruption of teeth (HP:0006288) | 1.46749741 |
| 117 | Hypoplasia of the fovea (HP:0007750) | 1.44107692 |
| 118 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.44107692 |
| 119 | Febrile seizures (HP:0002373) | 1.36749547 |
| 120 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.35556915 |
| 121 | Epileptic encephalopathy (HP:0200134) | 1.34819512 |
| 122 | Dysdiadochokinesis (HP:0002075) | 1.29994114 |
| 123 | Cystic liver disease (HP:0006706) | 1.25783562 |
| 124 | Retinal detachment (HP:0000541) | 1.24681121 |
| 125 | Pancreatic cysts (HP:0001737) | 1.23756849 |
| 126 | Astigmatism (HP:0000483) | 1.17818399 |
| 127 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.17120062 |
| 128 | Chorioretinal coloboma (HP:0000567) | 1.12111584 |
| 129 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.09521946 |
| 130 | Sclerocornea (HP:0000647) | 1.01019464 |
| 131 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.99366611 |
| 132 | Progressive cerebellar ataxia (HP:0002073) | 0.98860488 |
| 133 | Visual hallucinations (HP:0002367) | 0.98366636 |
| 134 | Truncal ataxia (HP:0002078) | 0.98096509 |
| 135 | Left ventricular hypertrophy (HP:0001712) | 0.97716832 |
| 136 | Prolonged QT interval (HP:0001657) | 0.96694057 |
| 137 | Recurrent sinusitis (HP:0011108) | 0.94691439 |
| 138 | Abnormality of the fingertips (HP:0001211) | 0.93727514 |
| 139 | Hypermetropia (HP:0000540) | 0.93707887 |
| 140 | Genetic anticipation (HP:0003743) | 0.91774526 |
| 141 | Broad foot (HP:0001769) | 0.90895923 |
| 142 | Specific learning disability (HP:0001328) | 0.89856347 |
| 143 | Furrowed tongue (HP:0000221) | 0.88121098 |
| 144 | Abnormality of midbrain morphology (HP:0002418) | 0.83941733 |
| 145 | Molar tooth sign on MRI (HP:0002419) | 0.83941733 |
| 146 | Chronic hepatic failure (HP:0100626) | 0.83257994 |
| 147 | Decreased testicular size (HP:0008734) | 0.82846861 |
| 148 | Asthma (HP:0002099) | 0.82413857 |
| 149 | Macroorchidism (HP:0000053) | 0.82219154 |
| 150 | Septo-optic dysplasia (HP:0100842) | 0.80720442 |
| 151 | Abnormality of dental color (HP:0011073) | 0.79000998 |
| 152 | Corneal dystrophy (HP:0001131) | 0.76553521 |
| 153 | Congenital hepatic fibrosis (HP:0002612) | 0.75347581 |
| 154 | Abnormal EKG (HP:0003115) | 0.75064191 |
| 155 | Anencephaly (HP:0002323) | 0.73266816 |
| 156 | Syncope (HP:0001279) | 0.71440328 |
| 157 | Broad-based gait (HP:0002136) | 0.71186992 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.70753532 |
| 159 | Postaxial hand polydactyly (HP:0001162) | 0.69959272 |
| 160 | Nephronophthisis (HP:0000090) | 0.67133909 |
| 161 | Aqueductal stenosis (HP:0002410) | 0.66169718 |
| 162 | Postaxial foot polydactyly (HP:0001830) | 0.64810443 |
| 163 | Hypodontia (HP:0000668) | 0.64460325 |
| 164 | Hypoventilation (HP:0002791) | 0.63979042 |
| 165 | Abnormality of the parathyroid morphology (HP:0011766) | 0.63823331 |
| 166 | Depression (HP:0000716) | 0.62463726 |
| 167 | Dental crowding (HP:0000678) | 0.62392878 |
| 168 | Postural instability (HP:0002172) | 0.62090613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.19501084 |
| 2 | PBK | 4.73205004 |
| 3 | MET | 3.86463259 |
| 4 | TIE1 | 3.51216277 |
| 5 | PINK1 | 3.27734484 |
| 6 | STK39 | 3.26222061 |
| 7 | EPHA2 | 3.02328732 |
| 8 | STK38L | 2.94918636 |
| 9 | LATS2 | 2.58965905 |
| 10 | OXSR1 | 2.38970414 |
| 11 | IRAK2 | 2.19661342 |
| 12 | GRK1 | 11.8137298 |
| 13 | MAP3K10 | 1.82368485 |
| 14 | EPHB2 | 1.80662294 |
| 15 | CAMK1G | 1.77164873 |
| 16 | STK24 | 1.76495221 |
| 17 | MUSK | 1.76151162 |
| 18 | PTK2B | 1.74388726 |
| 19 | SIK2 | 1.68024742 |
| 20 | CAMK1D | 1.63193958 |
| 21 | CDK12 | 1.62763848 |
| 22 | INSRR | 1.59895001 |
| 23 | MAPK7 | 1.51777153 |
| 24 | FER | 1.44890649 |
| 25 | TTN | 1.43150380 |
| 26 | HIPK2 | 1.42669635 |
| 27 | ADRBK1 | 1.42467518 |
| 28 | MAPK12 | 1.41051610 |
| 29 | BMX | 1.40044667 |
| 30 | BRD4 | 1.39118749 |
| 31 | STK38 | 1.38886323 |
| 32 | PAK6 | 1.35936639 |
| 33 | NME1 | 1.32467355 |
| 34 | PTK2 | 1.32371520 |
| 35 | MARK2 | 1.27897695 |
| 36 | KDR | 1.23886309 |
| 37 | STK3 | 1.22401982 |
| 38 | TAOK3 | 1.21170069 |
| 39 | SGK223 | 1.16746381 |
| 40 | SGK494 | 1.16746381 |
| 41 | SGK2 | 1.16078334 |
| 42 | ERBB2 | 1.12778369 |
| 43 | SGK3 | 1.08591227 |
| 44 | CSNK1D | 1.06978471 |
| 45 | RPS6KA4 | 1.05602255 |
| 46 | MAP3K4 | 1.03628031 |
| 47 | PDK2 | 1.01361934 |
| 48 | MARK1 | 1.00935320 |
| 49 | PRKD3 | 0.99258048 |
| 50 | MST4 | 0.98954452 |
| 51 | WNK1 | 0.97855489 |
| 52 | PRKCH | 0.95103815 |
| 53 | CAMKK1 | 0.94422893 |
| 54 | TRPM7 | 0.94054840 |
| 55 | DYRK1A | 0.90113567 |
| 56 | ICK | 0.89824049 |
| 57 | ACVR1B | 0.86435439 |
| 58 | NEK1 | 0.86390045 |
| 59 | PDGFRA | 0.85696065 |
| 60 | PRKCZ | 0.78230778 |
| 61 | TTK | 0.77157111 |
| 62 | NEK9 | 0.76902958 |
| 63 | MTOR | 0.75809608 |
| 64 | MKNK2 | 0.75071277 |
| 65 | PRKAA1 | 0.75005763 |
| 66 | CDK3 | 0.74792028 |
| 67 | TGFBR1 | 0.74386591 |
| 68 | AKT3 | 0.73890738 |
| 69 | BRSK2 | 0.73774789 |
| 70 | LATS1 | 0.73445549 |
| 71 | PRKAA2 | 0.72883874 |
| 72 | PRKCB | 0.72179585 |
| 73 | MAP3K2 | 0.68786126 |
| 74 | SIK1 | 0.67147469 |
| 75 | PNCK | 0.67041508 |
| 76 | MAP2K7 | 0.64223251 |
| 77 | CAMK2D | 0.63144871 |
| 78 | CDK9 | 0.61947833 |
| 79 | PRKD2 | 0.61496986 |
| 80 | PDGFRB | 0.61051812 |
| 81 | TGFBR2 | 0.61040808 |
| 82 | ERBB4 | 0.60419456 |
| 83 | DYRK1B | 0.60413828 |
| 84 | SGK1 | 0.59218750 |
| 85 | GRK5 | 0.58868525 |
| 86 | RPS6KA3 | 0.57670580 |
| 87 | CAMK1 | 0.57402068 |
| 88 | FRK | 0.57261966 |
| 89 | NEK2 | 0.56320320 |
| 90 | MAP3K7 | 0.55218731 |
| 91 | PHKG1 | 0.54813874 |
| 92 | PHKG2 | 0.54813874 |
| 93 | PRKACG | 0.53738213 |
| 94 | PLK2 | 0.53399021 |
| 95 | PAK4 | 0.52721756 |
| 96 | ERN1 | 0.52217746 |
| 97 | CAMK4 | 0.51597925 |
| 98 | BMPR1B | 0.50934850 |
| 99 | GSK3B | 0.50765715 |
| 100 | AKT2 | 0.50472598 |
| 101 | MAP3K3 | 0.48694242 |
| 102 | MAPK14 | 0.48635401 |
| 103 | FGFR1 | 0.48164731 |
| 104 | PRKDC | 0.46921122 |
| 105 | BCR | 0.46534258 |
| 106 | MAPK10 | 0.45468385 |
| 107 | MYLK | 0.44537727 |
| 108 | PRKG2 | 0.43852321 |
| 109 | CDK5 | 0.43410187 |
| 110 | MAPK9 | 0.42825367 |
| 111 | FES | 0.42581901 |
| 112 | FGFR2 | 0.42064185 |
| 113 | NEK6 | 0.40987627 |
| 114 | STK11 | 0.39790117 |
| 115 | DDR2 | 0.38529357 |
| 116 | PLK3 | 0.37535947 |
| 117 | IGF1R | 0.37451075 |
| 118 | CDK1 | 0.36863255 |
| 119 | FGFR3 | 0.36146399 |
| 120 | NTRK1 | 0.35984958 |
| 121 | CASK | 0.35767618 |
| 122 | CDC42BPA | 0.34926765 |
| 123 | RPS6KB1 | 0.34788536 |
| 124 | RET | 0.34690129 |
| 125 | PKN1 | 0.34490920 |
| 126 | YES1 | 0.33307988 |
| 127 | EPHA3 | 0.31934212 |
| 128 | PRKACA | 0.31071285 |
| 129 | PRKCI | 0.28810286 |
| 130 | SRC | 0.28303374 |
| 131 | FGFR4 | 0.27726104 |
| 132 | CCNB1 | 0.27519840 |
| 133 | PRKCA | 0.27516090 |
| 134 | RIPK1 | 0.27045176 |
| 135 | ATM | 0.25382365 |
| 136 | MAPK8 | 0.25341244 |
| 137 | PIK3CA | 0.25329294 |
| 138 | CHEK2 | 0.25043489 |
| 139 | PTK6 | 0.24917441 |
| 140 | MAP2K4 | 0.24740420 |
| 141 | PRKD1 | 0.24695747 |
| 142 | ALK | 0.24556642 |
| 143 | CAMK2A | 0.24426580 |
| 144 | ATR | 0.24210167 |
| 145 | TRIB3 | 0.24162602 |
| 146 | CAMK2G | 0.24023823 |
| 147 | PRKG1 | 0.22681652 |
| 148 | MAPK3 | 0.22561776 |
| 149 | BRSK1 | 0.22551041 |
| 150 | MINK1 | 0.22442175 |
| 151 | IRAK3 | 0.22418809 |
| 152 | MAP3K9 | 0.22082033 |
| 153 | CAMK2B | 0.21509890 |
| 154 | CDK7 | 0.21176604 |
| 155 | NUAK1 | 0.21161688 |
| 156 | PRKCG | 0.20878270 |
| 157 | MAPK1 | 0.20843150 |
| 158 | WNK4 | 0.20796888 |
| 159 | MAP3K6 | 0.19917544 |
| 160 | IRAK1 | 0.18981777 |
| 161 | ROCK1 | 0.17606605 |
| 162 | CHUK | 0.15996282 |
| 163 | INSR | 0.15168008 |
| 164 | PRKCE | 0.13416300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Adherens junction_Homo sapiens_hsa04520 | 2.44465627 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24459813 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.17079007 |
| 4 | * ABC transporters_Homo sapiens_hsa02010 | 2.13714712 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10251588 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09187097 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04665952 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 15.7352078 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.69345025 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.65161884 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65103043 |
| 12 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.58755674 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.47206821 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41285560 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37536480 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36677307 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36637527 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32735304 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32576133 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26546530 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24339768 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.21131801 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19913163 |
| 24 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.19621976 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18637238 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17416229 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15765796 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12270095 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07520431 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05341514 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04099105 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03480835 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01501026 |
| 34 | Axon guidance_Homo sapiens_hsa04360 | 0.99937925 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99644518 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97030232 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97009274 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96244748 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94161534 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89809105 |
| 41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.89645257 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 0.87179875 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85970140 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85492208 |
| 45 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.84885927 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83584590 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82787300 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81980558 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81713080 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79146851 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78822815 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76483169 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75760411 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75678047 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74717881 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72563177 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71801531 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69966450 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.68301159 |
| 60 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68046537 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64835229 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64239785 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63603357 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63305775 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62333761 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61055768 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60114881 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.59749888 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59666055 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59583147 |
| 71 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58050976 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55691285 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53678712 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53490342 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52104031 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50442497 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50304233 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49600506 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48849610 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48148204 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47925908 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47871735 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46074486 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45989221 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45840006 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44360124 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43382174 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42934248 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42374459 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42314674 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42262958 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.42230725 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41941685 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41911511 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41835859 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40653057 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40503311 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39774749 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.38939013 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38386266 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38279655 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37628089 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36823140 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35891412 |
| 105 | Purine metabolism_Homo sapiens_hsa00230 | 0.35773365 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35308377 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34972384 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.34519102 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32274170 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30779073 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29996656 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29920670 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28729765 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26616687 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25842896 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24953448 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24674828 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23503091 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23221773 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.22701335 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22597643 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22589371 |
| 123 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22451510 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22379462 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21060830 |
| 126 | Bile secretion_Homo sapiens_hsa04976 | 0.20078212 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20048830 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.19341434 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18086679 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17899447 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17811439 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.16483396 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16341551 |
| 134 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16212352 |
| 135 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16123623 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16010558 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.14716214 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14463667 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.14382846 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13549094 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.12948798 |
| 142 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.12869318 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12764373 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.12699644 |
| 145 | Alcoholism_Homo sapiens_hsa05034 | 0.11604290 |
| 146 | Glioma_Homo sapiens_hsa05214 | 0.11510536 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11267051 |
| 148 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10599774 |
| 149 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.10153486 |
| 150 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09349944 |
| 151 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.09231655 |
| 152 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09127655 |
| 153 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08450426 |
| 154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08287332 |
| 155 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.08243153 |
| 156 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08032581 |
| 157 | Taste transduction_Homo sapiens_hsa04742 | 0.07909317 |
| 158 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07716065 |
| 159 | Melanogenesis_Homo sapiens_hsa04916 | 0.06549569 |
| 160 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06492503 |
| 161 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.06045915 |
| 162 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.05936725 |
| 163 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.05873305 |
| 164 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.05812888 |
| 165 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.05228082 |
| 166 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05124262 |
| 167 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.04627621 |

